Join
Live feed
·
PRReleasevia Quantisnow
Acurx Pharmaceuticals Inc. logo

Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACXP (Acurx Pharmaceuticals Inc.) and more on Quantisnow.